Pathway enrichment analysis demonstrated that specific CLDN genes, such as CLDN14 and CLDN11, regulated key pathways, including apoptosis, cell cycle, and DNA damage repair, suggesting their potential roles in glioma progression (Figure 1g). The gene discussed is CLDN11; the disease is central nervous system cancer.